449 related articles for article (PubMed ID: 15987795)
1. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
[TBL] [Abstract][Full Text] [Related]
2. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
[TBL] [Abstract][Full Text] [Related]
3. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
[TBL] [Abstract][Full Text] [Related]
4. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis.
Nemoto Y; Kanai T; Kameyama K; Shinohara T; Sakamoto N; Totsuka T; Okamoto R; Tsuchiya K; Nakamura T; Sudo T; Matsumoto S; Watanabe M
J Immunol; 2009 Oct; 183(8):5059-68. PubMed ID: 19786550
[TBL] [Abstract][Full Text] [Related]
5. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
[TBL] [Abstract][Full Text] [Related]
8. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis.
Obermeier F; Strauch UG; Dunger N; Grunwald N; Rath HC; Herfarth H; Schölmerich J; Falk W
Gut; 2005 Oct; 54(10):1428-36. PubMed ID: 15879013
[TBL] [Abstract][Full Text] [Related]
9. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
Aranda R; Sydora BC; McAllister PL; Binder SW; Yang HY; Targan SR; Kronenberg M
J Immunol; 1997 Apr; 158(7):3464-73. PubMed ID: 9120308
[TBL] [Abstract][Full Text] [Related]
10. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.
Wirtz S; Finotto S; Kanzler S; Lohse AW; Blessing M; Lehr HA; Galle PR; Neurath MF
J Immunol; 1999 Feb; 162(4):1884-8. PubMed ID: 9973454
[TBL] [Abstract][Full Text] [Related]
12. Continuous generation of colitogenic CD4(+) T cells in persistent colitis.
Tomita T; Kanai T; Fujii T; Nemoto Y; Okamoto R; Tsuchiya K; Totsuka T; Sakamoto N; Watanabe M
Eur J Immunol; 2008 May; 38(5):1264-74. PubMed ID: 18412157
[TBL] [Abstract][Full Text] [Related]
13. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
[TBL] [Abstract][Full Text] [Related]
14. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
15. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
16. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.
Fort MM; Leach MW; Rennick DM
J Immunol; 1998 Oct; 161(7):3256-61. PubMed ID: 9759840
[TBL] [Abstract][Full Text] [Related]
17. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo.
Gad M; Kristensen NN; Kury E; Claesson MH
Immunology; 2004 Dec; 113(4):499-508. PubMed ID: 15554928
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity.
Spahn TW; Ross M; von Eiff C; Maaser C; Spieker T; Kannengiesser K; Domschke W; Kucharzik T
Scand J Immunol; 2008 Mar; 67(3):238-44. PubMed ID: 18261038
[TBL] [Abstract][Full Text] [Related]
19. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
[TBL] [Abstract][Full Text] [Related]
20. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
